Interactions of Angiotensin II With Central Catecholamines

References

• Phillips M. I. Functions of angiotensin in the central nervous system. Ann Rev Physiol 1987; 49: 413–435
   PubMed Web of Science ®Google Scholar
• Saavedra J. M. Brain and pituitary angiotensin. Pharmacol. Rev. 1992; 13(2)329–380
   Google Scholar
• Mendelsohn F. A.O., Quirion R., Saavedra J. M., Aguilera G., Catt K. J. Autoradiographic localization of angiotensin receptor binding in rat brain. Proc. Natl. Acad. Sci. USA 1984; 81: 1575–1579
   PubMed Web of Science ®Google Scholar
• Mendelsohn F. A.O., Allen A. M., Clevers J., Denton D. A., Tarjan E., McKinley M. J. Localization of angiotensin II receptor binding in rabbit brain by in vitro autoradiography. J. Comp. Neurol. 1988; 270: 372–384
   PubMed Web of Science ®Google Scholar
• Speth R. C., Walmsley J. K., Gehlert D. R., Chernicky C. L., Barnes K. L., Ferrario C. M. Angiotensin II receptor localization in the canine. Brain Research 1984; 326: 137–143
   Web of Science ®Google Scholar
• McKinley M. J., Allen A. M., Clevers J., Denton D. A., Mendelsohn F. A.O. Autoradiographic localization of angiotensin receptors in the sheep brain. Brain Research 1986; 375: 373–376
   PubMed Web of Science ®Google Scholar
• Allen A. M., Chai S. Y., Clevers J., McKinley M. J., Paxinos G., Mendelsohn F. A.O. Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata. J. Comp. Neurol. 1988; 269: 249–264
   PubMed Web of Science ®Google Scholar
• McKinley M. J., Allen A. M., Clevers J., Paxinos G., Mendelsohn F. A.O. Angiotensin receptor binding in human hypothalamus: autoradiographic localization. Brain Research 1987; 420: 375–379
   PubMed Web of Science ®Google Scholar
• Allen A. M., Paxinos G., McKinley M. J., Chai S. Y., Mendelsohn F. A.O. Localization and characterization of angiotensin II receptor binding sites in the human basal ganglia, thalamus, midbrain pons, and cerebellum. J. Comp. Neurol. 1991; 312: 291–298
   PubMed Web of Science ®Google Scholar
• Allen A. M., Paxinos G., Song K., Mendelsohn F. A.O. Localization of angiotensin receptor binding sites in the rat brain. Handbook of Chemical Neuroanatomy, Vol. 11: Neuropeptide receptors in the CNS, B. Bjorklund, T. Hokfelt, M. J. Kuhar. Elsevier Science Publishers. 1992; 1–37
   Google Scholar
• Marley P. D., Bunn S. J. Lack of effect of opiod compounds on angiotensin II responses of bovine adrenal medullary cells. Neurosci. Lett. 1988; 90(3)343–348
   PubMed Web of Science ®Google Scholar
• Li C. G., Majewski H., Rand M. J. Facilitation of noradrenaline release from sympathetic nerves in rat anococcygens muscle by activation of pre-junctional beta-adrenoceptors and angiotensin receptors. Br. J. Pharmacol 1988; 95(2)385–92
   PubMed Web of Science ®Google Scholar
• Wong P. C., Bernard R., Timmermans P. B.M.W.M. Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension 1992; 19: 663–667
   PubMed Web of Science ®Google Scholar
• Cassis L. A., Dwoskin L. P. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J. Neural Trans. 1991; 34(Suppl)129–137
   Google Scholar
• Lind R. W., Swanson L. W., Ganten D. Organisation of angiotensin II immunoreactive cells and fibres in the rat CNS. Neuroendocrinology 1985; 40: 2–24
   PubMed Web of Science ®Google Scholar
• Covenas R., Fuxe K., Cintra A., Aguirre J. A., Goldstein M., Ganten D. Evidence for the existence of angiotensin II like immunoreactivity in subpopulations of tyrosine hydroxylase immunoreactive neurons in the A1 and C1 area of the ventral medulla of the male rat. Neurosci. Lett. 1990; 114: 160–166
   PubMed Web of Science ®Google Scholar
• Fuxe K., Ganten D., Hokfelt T., Bolme P. Immunohistochemical evidence for the existence of angiotensin-II containing nerve terminals in the brain and spinal cord of the rat. Neurosci. Lett. 1976; 2: 229–234
   PubMed Web of Science ®Google Scholar
• Meldrum M. J., Xue C-S., Badino L., Westfall T. C. Angiotensin facilitation of noradrenergic neurotransmission in central tissues of the rat: effects of sodium restriction. J. Cardiovas. Pharmacol 1984; 6: 989–995
   PubMed Web of Science ®Google Scholar
• Garcia-Sevilla J. A., Dubocovich M. L., Langer S. Z. Angiotensin II facilitates the potassium-evoked release of 3H-noradrenaline from the rabbit hypothalamus. Eur. J. Pharmacol. 1979; 56: 173–176
   PubMed Web of Science ®Google Scholar
• Schacht U. Effects of angiotensin II and ACE inhibitors on electrically stimulated noradrenaline release from superfused rat brain slices. Clin. Exp. Hypertension 1984; A6(10–11)1847–1851
   Google Scholar
• Sumners C. Norepinephrine increases angiotensin II binding in rat brain synaptosomes. Brain. Res. Bull. 1992; 28: 411–415
   PubMed Web of Science ®Google Scholar
• Haulica I., Coculescu M., Ghinea E., et al. Biosynthesis of isorenin in cell cultures from pineal glands of adult and newborn rats. Life Sci. 1980; 27: 809–813
   PubMed Web of Science ®Google Scholar
• Hirose S., Yokosawe H., Inagami T., Workman J. Renin and prorenin in hog brain: ubiquitous distribution and high concentration in the pituitary and pineal. Brain Research 1980; 191: 489–499
   PubMed Web of Science ®Google Scholar
• Finocchiaro L. M.E., Goldstein D. J., Finkielman S., Nahmod V. E. Interaction of angiotensin II with the cholinergic and noradrenergic systems in the rat pineal gland: regulation of indole metabolism. Endocrinology 1990; 126: 59–66
   Web of Science ®Google Scholar
• Stadler T., Veltmar A., Qadri F., Unger T. Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats. Brain Research 1992; 569: 117–122
   PubMed Web of Science ®Google Scholar
• Sumners C., Phillips M. I. Central injection of angiotensin II alters catecholamine activity in rat brain. Am. J. Physiol. 1983; 244: R257–R263
   PubMed Web of Science ®Google Scholar
• Tomaszewwicz M., Micossi L. G., Bielarczyk H., Luszawska D., Santarelli I., Szutowicz A. Differential effects of angiotensin II and eledoisin on monoamine A and B activities in rat brain. J. Neurochem. 1991; 56: 729–732
   PubMed Web of Science ®Google Scholar
• Qadri F., Badoer E., Stadler T., Unger T. Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats: a brain microdialysis study. Brain Research 1991; 563(1–2)137–141
   PubMed Web of Science ®Google Scholar
• Ferrari A. C., de Arruda Cambargo L. A., Saad W. A., Renzi A., De Luca L. A., Jr, Menani J. V. Role of the al- and a2-adrenoceptors of the lateral hypothalamus in the dipsogenic response to central angiotensin II in rats. Brain Research 1991; 560: 291–296
   PubMed Web of Science ®Google Scholar
• Sumners C., Woodruff G. N., Poat J. A., Munday K. A. The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol. Psychopharmacology 1979; 60: 291–294
   PubMed Web of Science ®Google Scholar
• Fitzsimons J. T., Setler P. E. The relative importance of central nervous catecholaminergic and cholinergic mechanisms in drinking in response to angiotensin and other thirst stimuli. J. Physiol. 1975; 250: 613–631
   PubMed Web of Science ®Google Scholar
• Gordon F. J., Brody M. J., Johnson A. K. Regional depletion of central nervous system catecholamines: effect on blood pressure and drinking behaviour. Brain Research 1985; 345: 285–297
   PubMed Web of Science ®Google Scholar
• Bellin S. I., Bhatnagar R. K., Johnson A. K. Periventricular noradrenergic systems are critical for angiotensin-induced drinking and blood pressure responses. Brain Research 1987; 403: 105–112
   PubMed Web of Science ®Google Scholar
• McRae-Degeuree A., Bellin S. I., Landas S. K., Johnson A. K. Fetal noradrenergic transplants in amine-depleted basal forebrain nuclei restore drinking to angiotensin. Brain Research 1986; 374: 162–166
   PubMed Web of Science ®Google Scholar
• Baranowska D., Braszko J. J., Wisniewski K. Effect of angiotensin II and vasopressin on aquisition and extinction of conditioned avoidance in rats. Psychopharmacology 1983; 81: 247–251
   PubMed Web of Science ®Google Scholar
• Braszko J. J., Wisniewski K. Effect of angiotensin on the central action of dopamine. Pol. J. Pharmacol. Pharm 1976; 667: 672
   Google Scholar
• Braszko J. J., Wisniewski K., Kupryszewski G., Witezuk B. Psychotropic effects of angiotensin II and angiotensin III in rats: locomotor and exploratory vs cognitive behavior. Behav. Brain Res 1987; 25: 195–203
   PubMed Web of Science ®Google Scholar
• Braszko J. J., Wisniewski K. Effect of angiotensin II and saralasin on motor activity and the passive avoidance behaviour of rats. Peptides 1988; 9: 475–479
   PubMed Web of Science ®Google Scholar
• Braszko J. J., Wisniewski K. α1 and α2-adrenergic receptor blockade influences angiotensin II facilitation of avoidance behaviour and stereotypy in rats. Psychoneuroendocrinology 1990; 15(4)239–252
   PubMed Web of Science ®Google Scholar
• Reader T. A., Briere R., Grondon L. Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: role of disulfide and sulfhydryl groups. Neurochem. Res. 1986; 11: 9–27
   PubMed Web of Science ®Google Scholar
• Sumners C., Phillips M. I., Raizada M. K. Angiotensin II stimulates changes in the norepinephrine content of primary cultures of rat brain. Neurosci. Lett. 1983; 36: 305–309
   PubMed Web of Science ®Google Scholar
• Sumners C., Raizada M. K. Angiotensin II stimulates norepinephrine uptake in hypothalamus/brainstem neuronal cultures. Am. J. Physiol. 1986; 250: C236–244
   PubMed Web of Science ®Google Scholar
• Raizada M. K., Muther T. F., Sumners C. Increased angiotensin II receptors in neuronal cultures from hypertensive rat brain. Am. J. Physiol. 1984; 247: C364–372
   PubMed Web of Science ®Google Scholar
• Diz D. I., Pirro N. T. Differential actions of angiotensin II and angiotensin (1–7) on transmitter release. Hypertension 1992; 19(suppl II)II-41–II-48
   Google Scholar
• Badoer E., Wurth H., Turck D., et al. Selective local action of angiotensin II on dopaminergic neurons in the rat hypothalamus in vivo. Naunyn Schmiedeberg's Arch. Pharmacol. 1990; 340: 31–35
   Google Scholar
• Sumners C., Myers L. M., Kalberg C. J., Raizada M. K. Physiological and pharmacological comparisons of angiotensin II receptors in neuronal and astrocyte glial cultures. Prog. Neurobiol 1990; 34: 355–385
   PubMed Web of Science ®Google Scholar
• Fitzsimons J. T., Setler P. E. Catecholaminergic mechanisms in angiotensin-induced drinking. J. Physiol. 1971; 218: 43P–44P
   PubMed Web of Science ®Google Scholar
• Georgiev V., Gyorgy L., Getova D., Markovska V. Some central effects of angiotensin II. Interactions with dopaminergic transmission. Bulg. Acad Sci. 1985; 11(4)19–26
   Google Scholar
• Banks R. J.A., Dourish C. T. The angiotensin receptor antagonists DuP 753 and WL 19 block apomorphine-induced stereotypy in the rat. Br. J. Pharmacol 1991; 104: 63P
   Google Scholar
• Hyttel T., Christensen A. V. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D1 and D2 receptors. J. Neural Trans. 1983; 18(Suppl)157–164
   Google Scholar
• Georgiev V., Kambourova T. Interaction between angiotensin and dopaminergic mechanisms at the convulsive seizure threshold. CR Acad. Bulg. Sci. 1984; 37: 391–393
   Google Scholar
• Georgiev V., Petkova B., Kambourova T. Adaptive changes in the effects of angiotensin II on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors. Meth. and Find. Exptl. Clin. Pharmacol. 1988; 10(5)295–299
   PubMed Web of Science ®Google Scholar
• Georgiev V., Stancheva S., Kambourova T., Getova D. Effect of angiotensinII on the vogel conflict paradigm and on the content of dopamine and noradrenaline in the brain. Bulg. Acad Sci. 1990; 16(1)32–37
   Google Scholar
• Simonnet G., Giorguieff-Chesselet M. F. Stimulating effect of angiotensin II on the spontaneous release of newly synthesized [3H] dopamine in rat striatal slices. Neurosci. Lett. 1979; 15: 153–158
   PubMed Web of Science ®Google Scholar
• Brown C. D., Barnes N. M. Angiotensin II stimulates dopamine release from rat striatal slices via the AT1 receptor. Br. J. Pharmacol 1993; 110: 92P, Abstract
   Web of Science ®Google Scholar
• Dwoskin L. P., Jewell A. L., Cassis L. A. DuP 753. a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in the rat striatum. Naunyn Schmiedeberg's Arch. Pharmacol. 1992; 345: 153–159
   Google Scholar
• Braszko J. J., Kupryszewski G., Witczuk B., Wisniewski K. Angiotensin II, some of its fragments and saralasin affect dopamine in the striatum but not in the olfactory tubercle. Pharmacological Research 1992; 25(suppl2)9–10
   PubMedGoogle Scholar
• Allen A. M., MacGregor D. P., Chai S. Y., et al. Angiotensin II receptor binding associated with nigro-striatal dopaminergic neurones in human basal ganglia. Ann. Neurol. 1992; 32: 339–344
   PubMed Web of Science ®Google Scholar
• Mendelsohn F. A.O., Jenkins T. A., Berkovic S. F. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Research 1993; 613: 221–229
   PubMed Web of Science ®Google Scholar
• Barnes N. M., Champancria S., Costall B., Kelly M. E., Murphy D. A., Naylor R. J. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradisgm. Neuroreport 1990; 1(3–4)239–242
   PubMedGoogle Scholar
• Wong P. C., Price W. A., Chui A. T., et al. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 1990; 252: 719–725
   PubMed Web of Science ®Google Scholar
• Fregley M. J., Rowland N. E. Effect of DuP753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats. P.S.E.B.M. 1992; 199: 158–164
   PubMed Web of Science ®Google Scholar
• Song K., Zhuo J., Mendelsohn F. A.O. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors. Br. J. Pharmacol 1991; 104: 771–772
   PubMed Web of Science ®Google Scholar
• Li Z., Bains J. S., Ferguson A. V. Functional evidence that the angiotensin antagonist losartan crosses the blood brain barrier. Brain. Res. Bull. 1993; 30: 33–39
   PubMed Web of Science ®Google Scholar
• Sakaguchi K., Jackson B., Chai S. Y., Mendelsohn F. A.O., Johnston C. I. Effects of perindopril on tissue angiotensin-converting enzyme demonstrated by quantitative in vitro autoradiography. J. Cardiovas. Pharmacol 1988; 12: 710–727
   PubMed Web of Science ®Google Scholar
• Chai S. Y., Perich R., Jackson B., Mendelsohn F. A.O., Johnston C. I. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme. Clin. Exp. Pharm. Physiol. 1992; 19(suppl 19)7–12
   Google Scholar
• Gohlke P., Scholkens B., Henning R., Urbach H., Unger T. Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and hoe 288. J. Cardiovas. Pharmacol 1989; 14(Suppl 4)S32–S36
   PubMedGoogle Scholar